Kiniksa Pharmaceuticals Ltd (KNSA) Insider Trading
- $71,248,379.44
- $49,850,524.58
- Sept. 5, 2025
- Eben Tessari
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Sept. 5, 2025 | COO | 13,389 | $35.66 | Sell | $477,451.74 | |
Sept. 4, 2025 | COO | 85,271 | $35.52 | Sell | $3,028,825.92 | |
Sept. 4, 2025 | Insider | 3,523 | $35.31 | Sell | $124,397.13 | |
Sept. 3, 2025 | CAO | 11,000 | $34.84 | Sell | $383,240.00 | |
Sept. 3, 2025 | COO | 15,091 | $35.50 | Sell | $535,730.50 | |
Aug. 18, 2025 | COO | 16,200 | $33.77 | Sell | $547,074.00 | |
Aug. 14, 2025 | Director | 78,233 | $33.09 | Sell | $2,588,729.97 | |
Aug. 13, 2025 | Director | 50,129 | $33.32 | Sell | $1,670,298.28 | |
Aug. 12, 2025 | Director | 49,407 | $32.40 | Sell | $1,600,786.80 | |
Aug. 6, 2025 | Insider | 29,325 | $32.55 | Sell | $954,528.75 | |
Aug. 5, 2025 | COO | 138,614 | $33.20 | Sell | $4,601,984.80 | |
Aug. 4, 2025 | CFO | 18,889 | $32.89 | Sell | $621,259.21 | |
Aug. 4, 2025 | CAO | 17,000 | $32.35 | Sell | $549,950.00 | |
July 14, 2025 | COO | 18,900 | $28.72 | Sell | $542,808.00 | |
June 16, 2025 | COO | 17,300 | $28.28 | Sell | $489,244.00 | |
June 11, 2025 | COO | 45,042 | $30.51 | Sell | $1,374,231.42 | |
June 11, 2025 | Director | 12,336 | $30.39 | Sell | $374,891.04 | |
June 10, 2025 | Director | 8,212 | $30.36 | Sell | $249,316.32 | |
June 10, 2025 | COO | 15,506 | $30.46 | Sell | $472,312.76 | |
June 9, 2025 | Director | 6,900 | $30.26 | Sell | $208,794.00 | |
June 9, 2025 | COO | 10,319 | $30.38 | Sell | $313,491.22 | |
June 3, 2025 | Insider | 27,594 | $29.02 | Sell | $800,777.88 | |
June 3, 2025 | CFO | 18,299 | $28.80 | Sell | $527,011.20 | |
June 3, 2025 | CAO | 15,211 | $28.75 | Sell | $437,316.25 | |
May 28, 2025 | CEO | 62,116 | $27.33 | Sell | $1,697,630.28 | |
May 27, 2025 | CEO | 19,317 | $27.01 | Sell | $521,752.17 | |
May 23, 2025 | CEO | 4,837 | $27.00 | Sell | $130,599.00 | |
May 19, 2025 | COO | 12,000 | $26.41 | Sell | $316,920.00 | |
May 13, 2025 | CEO | 2,872 | $27.03 | Sell | $77,630.16 | |
May 8, 2025 | CEO | 101 | $27.00 | Sell | $2,727.00 | |
May 7, 2025 | Insider | 200 | $27.00 | Sell | $5,400.00 | |
May 7, 2025 | CAO | 17,647 | $26.69 | Sell | $470,998.43 | |
May 5, 2025 | Insider | 6,272 | $28.00 | Sell | $175,616.00 | |
May 1, 2025 | Insider | 23,234 | $28.02 | Sell | $651,016.68 | |
April 30, 2025 | CFO | 21,254 | $26.95 | Sell | $572,795.30 | |
April 29, 2025 | Insider | 64,035 | $25.21 | Sell | $1,614,322.35 | |
April 21, 2025 | Insider | 18,259 | $20.29 | Sell | $370,475.11 | |
April 14, 2025 | COO | 12,000 | $20.48 | Sell | $245,760.00 | |
March 19, 2025 | CFO | 8,879 | $23.10 | Sell | $205,104.90 | |
March 17, 2025 | CFO | 11,464 | $23.10 | Sell | $264,818.40 | |
March 12, 2025 | CAO | 9,051 | $22.45 | Sell | $203,194.95 | |
March 12, 2025 | CFO | 36,372 | $22.25 | Sell | $809,277.00 | |
Feb. 10, 2025 | COO | 14,000 | $19.57 | Sell | $273,980.00 | |
Jan. 13, 2025 | COO | 14,000 | $18.24 | Sell | $255,360.00 | |
Dec. 5, 2024 | CFO | 1,123 | $21.25 | Sell | $23,863.75 | |
Dec. 3, 2024 | CFO | 8,969 | $21.45 | Sell | $192,385.05 | |
Oct. 15, 2024 | COO | 17,000 | $26.87 | Sell | $456,790.00 | |
Sept. 23, 2024 | COO | 17,500 | $24.99 | Sell | $437,325.00 | |
Sept. 3, 2024 | Insider | 60,692 | $26.12 | Sell | $1,585,275.04 | |
Aug. 27, 2024 | COO | 17,500 | $26.91 | Sell | $470,925.00 |
Insiders are both buying and selling Kiniksa Pharmaceuticals Ltd stock.
The insider traders at Kiniksa Pharmaceuticals Ltd are: Eben Tessari, Sanj K Patel, Mark Ragosa, John F Paolini, Michael R Megna, Ross Moat, Thomas W Beetham, Thomas Malley, Barry D Quart, James E Flynn, Cormorant Asset Management, Lp, Bros. Advisors Lp Baker, and Barry D. Quart
The most active insider trader at Kiniksa Pharmaceuticals Ltd is Eben Tessari with 17 trades.
Eben Tessari has sold the most Kiniksa Pharmaceuticals Ltd stock with a total value of $15,317,666.10.
Bros. Advisors Lp Baker has bought the most Kiniksa Pharmaceuticals Ltd stock with a total value of $108,000,000.00.
The most recent insider trade for Kiniksa Pharmaceuticals Ltd was on Sept. 5, 2025.
The single biggest insider buy for Kiniksa Pharmaceuticals Ltd was from Bros. Advisors Lp Baker with a total value of $54,000,000.00 on May 29, 2018.
The single biggest insider sell for Kiniksa Pharmaceuticals Ltd was from Eben Tessari with a total value of $4,601,984.80 on Aug. 5, 2025.